PAGANINI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 1.673
EU - Europa 1.037
AS - Asia 244
OC - Oceania 19
AF - Africa 8
SA - Sud America 2
Totale 2.983
Nazione #
US - Stati Uniti d'America 1.668
RU - Federazione Russa 369
PL - Polonia 266
IE - Irlanda 105
SE - Svezia 91
IT - Italia 80
CN - Cina 67
SG - Singapore 61
HK - Hong Kong 55
DE - Germania 44
JO - Giordania 26
GB - Regno Unito 21
UA - Ucraina 21
FI - Finlandia 18
AU - Australia 16
IN - India 13
CI - Costa d'Avorio 7
BE - Belgio 6
ES - Italia 6
CA - Canada 5
FR - Francia 5
TR - Turchia 5
VN - Vietnam 4
ID - Indonesia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
BD - Bangladesh 2
CH - Svizzera 2
TW - Taiwan 2
AZ - Azerbaigian 1
BR - Brasile 1
HU - Ungheria 1
KG - Kirghizistan 1
KR - Corea 1
NL - Olanda 1
PE - Perù 1
RO - Romania 1
SC - Seychelles 1
Totale 2.983
Città #
Santa Clara 492
Warsaw 266
Fairfield 153
Chandler 120
Dublin 105
Ashburn 88
Woodbridge 80
Cambridge 63
Seattle 63
Wilmington 61
Houston 51
Singapore 47
Ann Arbor 41
Jacksonville 41
Hong Kong 37
Altamura 36
Lawrence 36
Princeton 28
Beijing 20
Buffalo 18
Shanghai 18
Medford 15
Melbourne 15
Boston 13
Dearborn 13
Florence 12
Mumbai 11
Boardman 10
Kent 10
Moscow 10
New York 8
Abidjan 7
Milan 7
Brussels 6
Falls Church 6
Barcelona 5
Los Angeles 5
Norwalk 5
Dong Ket 4
Hefei 4
Helsinki 4
Izmir 4
San Diego 4
West Jordan 4
Yubileyny 4
Jakarta 3
Munich 3
Nanjing 3
Toronto 3
Andover 2
Auburn Hills 2
Auckland 2
Bern 2
Bremen 2
Falkenstein 2
Guangzhou 2
Hillsboro 2
Jinan 2
Montreal 2
Multan 2
Palermo 2
Redwood City 2
Salerno 2
Taipei 2
Acton 1
Baku 1
Bishkek 1
Brescia 1
Bristol 1
Calenzano 1
Columbia 1
Frankfurt Am Main 1
Frankfurt am Main 1
Hamburg 1
Hangzhou 1
Hounslow 1
Hwang Chow 1
Islamabad 1
Islington 1
Jaipur 1
Kilburn 1
Konya 1
Lima 1
London 1
Madrid 1
Maglod 1
Marino 1
Newcastle upon Tyne 1
Nürnberg 1
Padova 1
Paris 1
Phoenix 1
Prescot 1
Redmond 1
Romola 1
San Francisco 1
San Giuliano Terme 1
San Mateo 1
Secaucus 1
Seoul 1
Totale 2.128
Nome #
Time perception impairment in early-to-moderate stages of Huntington's disease is related to memory deficits 274
Huntington’s disease and Scalar Expectancy Theory: A memory-based time perception deficit 208
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 164
Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. 135
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion 121
Therapeutic options in a patient with MELAS and diabetes mellitus: follow-up after 6 months of treatment 121
Reply to Josef Finsterer “MELAS requires broad clinical and genetic work-up” 119
Suicidal ideation in a European Huntington's disease population 119
Clinical and genetic characteristics of late-onset Huntington's disease 119
Identification of new presenilin gene mutations in early-onset familial Alzheimer disease 118
Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease 114
SEMANTIC ACCESS AND LONG TERM MEMORY: A COMPARISION BETWEEN PARKINSONS DISEASE DE NOVO AND AGE ASSOCIATED MEMORY IMPAIRMENT. 107
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. 105
Discrepancies in reporting the CAG repeat lengths for Huntington's disease 101
Evaluation of cognitive and language side effects of topiramate in patients with epilepsy, and effectiveness of counseling and speech therapy interventions 100
Recognition of category-related visual stimuli in Parkinson's disease: before and after pharmacological treatment. 95
DEEP BRAIN STIMULATION IN PATIENTS AFFECTED BY PARKINSON'S DISEASE: A COMPARISION BETWEEN NEUROPSYCHOLOGICAL EVALUATION BEFORE AND AFTER SURGERY 94
Prediction of seizure recurrence risk following discontinuation of antiepileptic drugs 93
Response: Brightening the crystal ball: A constructive reappraisal of the postwithdrawal seizure relapse prediction model 88
Differential diagnosis between epilepsy and syncope. The Oesys study (overlapping between epilepsy and syncope study): Preliminary results 84
The spectrum of auto-immune encephalitis: Clinical characterisation and comparison between different syndromes defined by 2016 diagnostic criteria 84
Seizure recurrence risk after discontinuation of anti-seizure medications: prognostic factors and development of a new predictive scale 79
Efficacia di una batteria specifica per la valutazione del danno lobare in pazienti con epilessia focale 79
Autoimmune epilepsy in drug resistent and in new onset refractory epilepsy 79
Guidelines for the diagnosis of dementia and Alzheimer's disease 76
Assessment of distinctive neuropsychological impairment in frontal and temporal lobe epilepsy. 74
null 67
Totale 3.017
Categoria #
all - tutte 8.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.395


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020214 0 0 0 0 0 0 56 53 38 25 35 7
2020/2021199 22 17 10 22 7 27 11 17 18 21 8 19
2021/2022187 7 25 13 8 4 12 9 12 6 9 34 48
2022/2023530 39 113 38 20 43 83 68 21 80 5 9 11
2023/2024180 9 24 24 10 17 12 8 44 3 9 13 7
2024/20251.110 44 130 117 217 392 207 3 0 0 0 0 0
Totale 3.017